Martin Felices

19PUBLICATIONS
122CO-AUTHORS
Micro- and nanosystemsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 13, 2026
Reprogramming endogenous NK circuits by highly efficient nonviral genome editing.

|Apr 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer.

|Dec 21, 2025
TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8+ T-cell subsets in lymph nodes and tumors.

Varghese K George, Hing C Wong, Martin Felices

|Jul 24, 2025
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.

Melissa J Khaw, Nicholas A Zorko, Philippa R Kennedy

|Feb 12, 2025
CD56bright cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cells.

Maria L Guevara Lopez, Ann Gebo, Monica Parodi

|Nov 15, 2024
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer.

Shee Kwan Phung, Nicholas A Zorko, Yvette Soignier

Pageof 4

Frequent Collaborators

9 joint publications

Jeffrey S Miller

6 joint publications

Philippa R Kennedy

3 joint publications

Nicholas A Zorko

3 joint publications

Melissa Khaw